Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer

Overview of attention for article published in Breast Cancer Research and Treatment, May 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,687 followers.

RT @HealthPolicyDPM: New paper by HPI members @ChrisLuPhD, @mxcallah, @Jwharam, @drossdeg, et al, examines effects of high-deductible healt…

RT @HealthPolicyDPM: New paper by HPI members @ChrisLuPhD, @mxcallah, @Jwharam, @drossdeg, et al, examines effects of high-deductible healt…

New paper by HPI members @ChrisLuPhD, @mxcallah, @Jwharam, @drossdeg, et al, examines effects of high-deductible health plans on OOP costs and utilization of adjuvant hormonal therapy (AHT) of patients with #breastcancer https://t.co/KND60uGmGu

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.